Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The dynamics of the market structure for the prevalence and awareness about neurological conditions among an aging population are some demographic factors contributing towards this dynamic environment observed in DAVF Treatments. Different types of vascular disorders such as AVMs become common amongst older persons who usually face higher risks associated with such complications. Aging population leads changes in demographic landscape resulting into provision of tailor-made treatment approaches based on various patients’ needs only.
The continued evolution in diagnostic technologies has crucial influence over how the DAVF Treatment market behaves. The coming of sophisticated imaging tools such as Digital subtraction angiography, Magnetic resonance angiography (MRA) and computed tomography angiography (CTA) has made it easier to diagnose and characterize DAVFs. This is because early and accurate diagnosis determines the best approach for treatment of these conditions, prompting high demand in the market for state-of-the-art diagnostic devices that can provide precise visualization of abnormal blood connections.
Current trends imply that aging population contributes most demographic changes in DAVF Treatment market. While older individuals are more often diagnosed with this disorder, the increase in number of aged people results into higher prevalence rate since there is a relationship between age and vasculature diseases being one of them. Thus, there must be an adjustment according to demographic variations on the part of a changing marketplace to address specific preferences held by various patients’ groups.
In addition, research as well as technological advances occupy a key niche within the DAVF Treatment industry trends. The landscape of managing AVMs has changed due to incorporating endovascular procedures like embolization, stent placement and neurosurgeries among others aimed at treating these diseases. On-going studies seek to improve safety profiles and treatment efficacy associated with these methods while also exploring new technologies like flow diverters.
Among those who compete with each other in this field are: doctors specializing in neuro intervention; surgeons specializing in neuro; representatives coming from companies manufacturing medical equipment etc. Therefore, companies operating in this sector carry out research and development works aimed at enhancing existing treatment modalities and introducing new technologies.
Although the DAVF Treatment market has made great strides forward, there are still problems yet to be addressed. This is because DAVF presentation varies and treatment decisions can become difficult with time.
Dural Arteriovenous Fistulas Treatment Market Highlights:
Dural Arteriovenous Fistulas Treatment Market Scenario
The dural arteriovenous fistulas treatment market is expected to grow at a CAGR of 6.60% during the forecast period 2022-2030.Dural arteriovenous fistulas (DAVF) is caused by abnormal connections between arteries and veins in a protective membrane on the outer layer of the brain and spine; it is a rare disease. These abnormal blood vessels divert blood from the normal paths. If the volume of diverted blood flow is large, tissue downstream may not receive an adequate blood and oxygen supply. The symptoms vary, depending on the location of fistulae. Headaches are among the most common symptoms with all types of DAVFs. Other symptoms include visual problems, ringing in ears, heart strokes, and others.
Increasing prevalence of brain injury and neurological disorders, increasing investment in biotechnology and pharmaceutical industries in R&D, and rising need for the better treatment methods drive the growth of the dural arteriovenous fistulas treatment market. Moreover, favorable reimbursement policies, increased applications, and significant investments in the development of advance technologies for the treatment methods likely to fuel the dural arteriovenous fistulas treatment market growth during the forecast period 2017-2023.
As per the Centers for Disease Control and Prevention in 2014, about 2.8 million TBI-related Emergency Department (ED) visits, hospitalizations, and deaths occurred in the United States. TBI (traumatic brain injury) contributed to the deaths of nearly 50,000 people. It was diagnosed in over 282,000 hospitalized cases and over 2.5 million ED visits. These consisted of TBI alone or TBI in combination with other injuries. Adults aged over 75 years have the highest rates of TBI-related hospitalization and deaths.
According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies. This is far higher as compared to the number of gastrointestinal disorders, or cancers, and is expected to increase further over the coming years.
However, higher cost of these treatment procedure may hamper the dural arteriovenous fistulas treatment market growth during the corresponding period.
Intended Audience
- Pharmaceutical Companies
- Research and Development (R&D) Companies
- Government Research Institute
- Academic Institutes and Universities
Figure: Global Dural Arteriovenous Fistulae Treatment Market, by Region Market Share, 2016 (%)
Sources: Annual reports, Press release, White paper, Company presentation
Segmentations
The dural arteriovenous fistulae treatment market is segmented on the basis of type, treatment, and end user.
On the basis of type, the dural arteriovenous fistulas treatment market is segmented into type I, type II, and type III.
On the basis of application, the dural arteriovenous fistulas treatment market is segmented into surgery, stereotactic radiosurgery, embolization, and others.
On the basis of end user, the dural arteriovenous fistulas treatment market is segmented into hospitals & clinics, ambulatory surgical centers, and others.Â
Regional Analysis
The Americas dominates the dural arteriovenous fistulas treatment market owing to developing  technology, increasing cases of brain injury, rising prevalence of neurological disorders, growing healthcare spending, and increasing government support for research & development. Furthermore, increasing R&D activities and the presence of major companies have fuelled the growth of the market in this region.
Europe holds the second position in the dural arteriovenous fistulas treatment market. It is expected that the government support for research & development and availability of funds for research may drive the market in European region over the review period.
Asia Pacific is the fastest growing dural arteriovenous fistulas treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing new opportunities in countries such as China, India, Japan, and South Korea projected to emerge as the fastest growing market across the globe. Furthermore, increasing demand for the neurological treatment may lead to the use of advanced equipment, which, in turn, will increase the growth of the dural arteriovenous fistulas treatment market in the region.
On the other hand, the Middle East and Africa holds the least share of the market due to limited medical facilities, lack of funds for research and development, and poor political conditions, especially, in Africa.
Key Players
Some of key the players in the dural arteriovenous fistulas treatment market are BD (U.S.), Medtronic (U.S.), B. Braun Melsungen AG (Germany), Cook (U.S.), Teleflex Incorporated (U.S.), Fresenius Medical Care AG & Co. KGaA (Germany), NxStage Medical, Inc.(U.S.), and Poly Medicure Limited.Â
Research Methodology 
Sources: Annual reports, Press release, White paper, and Company presentation
Â
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
